News

Hyperacuity Grid

This uses your hyperacuity to easily locate areas of visual distortion possibly caused by fluid or blood leakage in your retina. Print this page, then cut out the strip of dots below. With one eye shut, gaze at the center of the graph from a distance of about 12 inches (30 cm). Slide the strip [Read More]

X-82 Oral Medication May Reduce Number of Intravitreal Injections for Wet AMD

No cure yet exists for wet AMD, but three FDA-approved therapies are slowing the progress of wet AMD and reducing the amount of vision loss. These treatments are ranibizumab (Lucentis), aflibercept (Eylea), and off-label bevacizumab (Avastin). These medications are highly successful, but they must be injected directly into the eye, and the treatment often needs [Read More]

Iluvien Similar to Anti-VEGF Drugs as Treatment for Diabetic Retinopathy

(Updated 12/5/2017) On February 16, Charles C. Wykoff, MD, PhD, announced to the American Academy of Ophthalmology annual meeting that Iluviuan (fluocinolone acetonide) treatment, after 1.3 injections over 3 years in the FAME trials, “significantly reduced progression to prolific diabetic retinopathy from 31% to 17%, a similar reduction as observed with monthly anti-VEGF treatments.” Iluvian [Read More]

Lucentis effective for proliferative diabetic retinopathy

NIH-funded clinical trial marks first major advance in therapy in 40 years A clinical trial funded by the National Institutes of Health has found that the drug ranibizumab (Lucentis) is highly effective in treating proliferative diabetic retinopathy. The trial, conducted by the Diabetic Retinopathy Clinical Research Network (DRCR.net) compared Lucentis with a type of laser [Read More]

Medicare Covers Annual Eye Exams for Diabetics

November is American Diabetes Month. To prevent diabetes-related vision loss, the American Academy of Ophthalmology recommends people with diabetes get a dilated eye exam each year.   One in four Americans age 65 or older has diabetes, putting them at increased risk for vision loss and blindness. Fortunately, diabetes-related vision loss is largely preventable with [Read More]